Human renal cancers resistant to IFN's antiproliferative action exhibit sensitivity to IFN's gene-inducing and antiviral actions Journal Article


Authors: Pfeffer, L. M.; Wang, C.; Constantinescu, S. N.; Croze, E.; Blatt, L. M.; Albino, A. P.; Nanus, D. M.
Article Title: Human renal cancers resistant to IFN's antiproliferative action exhibit sensitivity to IFN's gene-inducing and antiviral actions
Abstract: Purpose: Although treatment with interferon-alpha (IFN alpha) results in tumor regression in a subset (<20%) of patients with renal cell carcinoma, the underlying mechanisms for the resistance of renal cancer (RC) cells to IFN alpha is unknown. Materials and Methods: We examined 5 RC lines resistant and 5 RC lines sensitive to the antiproliferative effects of IFN alpha for differences in: 1) the number of IFN binding sites, 2) the number of signal-transducing IFNAR-1 chains of the IFN alpha receptor, 3) IFN alpha receptor structure, 4) IFN-stimulated gene (ISG) expression and 5) IFN alpha sensitivity in antiviral assays. Results: No structural alterations in the IFN alpha receptor were detected in any RC line examined, although varying numbers of ligand binding sites and IFNAR-1 signal transducer chains were present. All 5 IFN-sensitive, and 4 of 5 IFN-resistant RC lines were sensitive to the antiviral and gene-inducing actions of IFN alpha. Conclusions: The resistance of RC lines to IFN's antiproliferative action is not due to defects in ligand binding or in IFN-receptor structure. Our results indicate that the defective antiproliferative response in most RC cells is not due to their failure to induce the gene-inducing and antiviral effects of IFN alpha.
Keywords: phosphorylation; carcinoma, renal cell; carcinoma; transcription; expression; cell-lines; factor; protein-tyrosine kinase; interferons; interferon-alpha/beta receptor
Journal Title: Journal of Urology
Volume: 156
Issue: 5
ISSN: 0022-5347
Publisher: Elsevier Science, Inc.  
Date Published: 1996-11-01
Start Page: 1867
End Page: 1871
Language: English
ACCESSION: WOS:A1996VM11700111
DOI: 10.1016/s0022-5347(01)65555-1
PROVIDER: wos
PUBMED: 8863634
Notes: Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David M. Nanus
    66 Nanus
  2. Anthony P. Albino
    111 Albino